Logo

Abbott's ARCHITECT STAT High Sensitivity Troponin-I Blood Test Receives FDA Clearance to Detect Heart Attacks Faster and Accurately

Share this

Abbott's ARCHITECT STAT High Sensitivity Troponin-I Blood Test Receives FDA Clearance to Detect Heart Attacks Faster and Accurately

Shots:

  • Abbott's High Sensitivity Troponin-I blood test measures very low levels of troponin- allowing doctors to evaluate heart attack in patients within 2-4 hrs. of admission as the elevated level of Troponin-I proteins in the blood indicates cardiac muscles damage and improves the diagnosis in women
  • Abbott’s blood test is evaluated in 200+ studies for its role in identifying heart disease and cardiac events without affected by biotin interference. Abbott will launch the Heart Partnership Program which aid hospital care teams to implement blood test into their care pathway
  • The High Sensitivity Troponin I blood test is used on ARCHITECT analyzer along with ECG- clinical observations and information and patient symptoms to aid heart attack diagnosis

Click here to­ read full press release/ article

 | Ref: Abbott | Image: Abbott


Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions